Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
|Articles|July 6, 2015
Rebecca Sutphen Discusses Genetic Counseling and Testing
Author(s)Rebecca Sutphen
Rebecca Sutphen on genetic testing and counseling for people with a family history of hereditary cancers.
Advertisement
Rebecca Sutphen, breast cancer survivor, professor, Departments of Pediatrics and Oncologic Sciences, College of Medicine, University of South Florida, Chief Medical Officer, Informed Medical Decision, on genetic testing and counseling for people with a family history of hereditary cancers.
Advertisement
Related to this article
Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
Dr. Jacqueline Barrientos shares how a targeted therapy, a determined care team and a stranger’s generosity gave a 72-year-old man with hairy cell leukemia and kidney failure a second chance.
Dr. Robert Kreitman explains how CD22-targeted CAR T could help heavily pretreated patients.
An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
Psychiatrist Dr. Yesne Alici of Memorial Sloan Kettering Cancer Center answers questions about family relationships during cancer, from asking for help to talking with children and friends.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Advertisement
Advertisement
Trending on CURE
1
3 Quality-of-Life Results From ESMO 2026 Patients Should Know
2
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
3
3 ESMO 2026 Results in Endometrial and Breast Cancer to Know
4
Neuro-Oncologist Answers Common Questions About Brain Cancer Diagnosis and Treatment
5